Lifeboat Foundation

A new technique has been added to the CRISPR gene-editing toolbox. Known as PASTE, the system uses virus enzymes to “drag-and-drop” large sections of DNA into a genome, which could help treat a range of genetic diseases.

The CRISPR system originated in bacteria, which used it as a defense mechanism against viruses that prey on them. Essentially, if a bacterium survived a viral infection, it would use CRISPR enzymes to snip out a small segment of the virus DNA, and use that to remind itself how to fight off future infections of that virus.

Over the past few decades, scientists adapted this system into a powerful tool for genetic engineering. The CRISPR system consists of an enzyme, usually one called Cas9, which cuts DNA, and a short RNA sequence that guides the system to make this cut in the right section of the genome. This can be used to snip out problematic genes, such as those that cause disease, and can substitute them with other, more beneficial genes. The problem is that this process involves breaking both strands of DNA, which can be difficult for the cell to patch back up as intended, leading to unintended alterations and higher risks of cancer in edited cells.

Phages probably picked up DNA-cutting systems from microbial hosts, and might use them to fight other viruses.

Unnecessary playing with nature.

In January, Bennett’s doctors offered him the chance to receive a heart from a pig. He took it. “I know it’s a shot in the dark, but it’s my last choice,” he said in a press release from the University of Maryland Medical Center in Baltimore, where he was being treated. On 7 January, doctors transplanted the heart, which had been genetically modified so that the human body would tolerate it.

Bennett survived for eight weeks with his new heart before his body shut down. After his death, the research team learnt that the transplanted organ was infected with a pig herpesvirus that had not been detected by tests¹.

Continue reading “Will pigs solve the organ crisis? The future of animal-to-human transplants” »

Evidence-Based And Actionable Health, Wellness And Longevity Solutions — Dr. Renee DeHaan, Ph.D. — VP, Science & AI, InsideTracker

Dr. Renée Deehan, Ph.D. is the VP of Science & Artificial Intelligence at InsideTracker (https://www.insidetracker.com/), and leads a science team that builds and mines the world’s largest data set of blood, DNA, fitness tracking and phenotypic data from healthy people, creating evidence-based solutions that are simple, clear, and actionable.

Continue reading “Dr Renée Deehan — VP, Science & AI, InsideTracker — Evidence-Based And Actionable Wellness Solutions” »

Circa 2021:3

Surgical management of breast cancer often results in the absence of the breast. However, existing breast reconstruction methods may not meet the need for a replacement tissue. Tissue engineering with the use of emerging materials offers the promise of generating appropriate replacements. Three-dimensional (3D) printing technology has seen a significantly increased interest and application in medically-related fields in the recent years. This has been especially true in complex medical situations particularly when abnormal or complicated anatomical surgical considerations or precise reconstructive procedures are contemplated. In addition, 3D bio-printing which combines cells with bio-material scaffolds offers an exciting technology with significant applications in the field of tissue engineering. The purpose of this manuscript was to review a number of studies in which 3D printing technology has been used in breast reconstructive surgical procedures, and future directions and applications of 3D bio-printing.

Breast cancer is the most common cancer diagnosed among US women and is second only to lung cancer as a cause of cancer death among women as of 2019. Because ~268,600 (almost six times than DCIS) new cases prove to be an invasive type of breast cancer (1), many women had to choose the removal of the breast, with immediate consideration for a replacement tissue. Although this was satisfactory in many patients, either saline or gel-filled breast implants (2) do carry real risks of complications such as infection, capsular contracture, implant dislocation, or deformities (3, 4). The option of autologous reconstruction can be more texturally natural aesthetically, but it requires a more complex procedure, significant time and expense, and possible muscle weakness or hernia formation at the tissue donor site (5). Tissue engineering intends to address these limitations by combining the 3D printing technology with synthetic or natural structural elements.

Continue reading “3D Printing in Breast Reconstruction: From Bench to Bed” »

Researchers believe that synthetic muscle fibers could be used in a wide variety of sustainable and environmentally friendly industrial applications, including textiles, biomedicine, and tissue engineering. In a world where it takes up to 1,800 gallons of water to produce a single pair of jeans, the development of such environmentally safe processes that provide high-strength materials for industrial applications is a great step forward.

How strong can a muscle ever get? Can it have more endurance than metal? Can it be sturdier than Kevlar? While you might be inclined to answer the above in the negative, please pause, for scientists have succeeded in developing synthetic muscle that’s stronger than Kevlar. How about that for a flex?

The science and other stuff to know

Continue reading “Scientists Created Synthetic Muscle That’s Stronger Than Kevlar” »

High-Risk, High-Payoff Bio-Research For National Security Challenges — Dr. David A. Markowitz, Ph.D., IARPA

Dr. David A. Markowitz, Ph.D. (https://www.markowitz.bio/) is a Program Manager at the Intelligence Advanced Research Projects Activity (IARPA — https://www.iarpa.gov/) which is an organization that invests in high-risk, high-payoff research programs to tackle some of the most difficult challenges of the agencies and disciplines in the U.S. Intelligence Community (IC).

Continue reading “Dr. David Markowitz, PhD — IARPA — High-Risk, High-Payoff Research For National Security Challenges” »

^b Department of Polymer Science and Engineering and Key Laboratory of High Performance Polymer Materials and Technology of MOE, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210,023, China.

^c Institute of Chemical and Bioengineering, ETH Zurich, Vladimir Prelog Weg 1, 8093 Zurich, Switzerland.

Received 21st February 2019, Accepted 17th April 2019.

The fourth discussion of the NEW NOW program, “Transhumanism: Beyond the Human Frontier?”, took place on December 16.

Together with our guest experts, we tried to identify the latest technology that has either already become a reality or is currently in development, focusing on the ethical aspects of the consequences that ensue. We reflected on the question of whether the realization of transhumanist ideas is likely to entail a radical change in the ways people relate to one another. How far are we prepared to go in changing our bodies in order to attain these enhanced capacities? We will attempt to identify the “human frontier”, beyond which the era of posthumanism awaits.

Continue reading “NEW NOW. Transhumanism: beyond the human frontier?” »